Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Food and Drug Administration (FDA)
Biotech
Sanofi snags CMO from BioMarin—Chutes & Ladders
Sanofi snags CMO from BioMarin. Anti-aging outfit lands BioNTech vet. Acadia scoops seasoned dealmaker as business chief.
Darren Incorvaia
,
Zoey Becker
Aug 29, 2025 8:30am
Fierce Healthcare
HHS agencies no longer recognize union representation
Aug 25, 2025 1:30pm
After delay, Coya receives FDA go-ahead for phase 2 ALS trial
Aug 25, 2025 11:04am
FDA draft recommends all cancer trials collect OS data
Aug 20, 2025 10:59am
Regenxbio's Hunter gene therapy latest to face FDA delay
Aug 19, 2025 10:30am
Another biotech hit with FDA delay for ALS asset
Aug 18, 2025 11:01am
